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Clostridioides difficile is a Gram-positive, spore-forming, obligate anaerobic
bacterium which causes gastrointestinal disease and is a leading cause of nosocomial
infections. Although infection typically occurs following antibiotic therapy, in recent
years there has been an increase in infections which are not preceded by antibiotic use.
Additionally, community-associated infections and rates of disease recurrence have
increased. While it is understood that a healthy gastrointestinal microbiota provides
protection against infection, the molecular mechanisms which underly

s

ability to colonize and persist in the gut are mostly unknown. Building on work from
others that suggests C. difficile associates with the outer mucus layer during infection, we
utilized an in vitro mucus layer model to probe attachment and colonization mechanisms.
Using gene-interruption mutants of the major subunits of type IV pili and flagella, two
extracellular appendages implicated in adhesion, we observed that the presence of
flagella facilitates initial mucus attachment. Adhesion was variable across multiple
strains of C. difficile and was also dependent on the source of mucin derivation. When
mucin glycans were modified by mucin-degrading bacteria, C. difficile attachment
decreased in our model. Collectively, our findings suggest that adherence to mucin likely
influences

s ability to colonize and may offer novel strategies for future

therapeutics once the underlying mechanisms are better understood.

iii

ACKNOWLEDGMENTS
I would like to express my appreciation for my advisor, Dr. Kurt Piepenbrink, for
providing me with the opportunity to work and grow in his lab. Through his mentorship,
my interest in research and scientific curiosity has grown immensely.

confident they will serve me well in future pursuits.
I would also like to acknowledge the support and guidance provided by the
members of my advisory committee, Dr. Jennifer Auchtung and Dr. Devin Rose. Their
advice on this project, suggestions for navigating career decisions, and commitment to
my academic success were integral to my professional development and the completion
of this thesis. A special thanks to Dr. Jennifer Auchtung, Dr. Tommy Auchtung, and all
the members of the Auchtung laboratory for sharing space and time in the anaerobic
chamber.
Thank you to my laboratory mates, Leslie Ronish and Yafan Yu, for experimental
advice, help with preparing reagents, and companionship through the stressful days of
graduate work. Thank you to Hugh McCullough for mucus samples and training on
mammalian cell culture maintenance.
Finally, a huge thank you to family and friends near and far for advice, open ears,
and encour

your support over the years, and feel I

be able to adequately express my gratitude enough.
This research was performed in part in the Nebraska Nanoscale Facility National
Nanotechnology Coordinated Infrastructure and the Nebraska Center for Materials and

iv

Nanoscience, which are supported by the National Science Foundation under Award
ECCS: 2025298, and the Nebraska Research Initiative.

v

PREFACE
This thesis is comprised of three chapters. Chapter 1 includes a brief overview of
Clostridioides difficile infection and the current state of scientific knowledge regarding
mechanisms of colonization. Chapter 2 explores the possible role of two putative
colonization factors, type IV pili and flagella, in mediating C. difficile adhesion to mucus.
Additionally, this chapter includes investigations into the conservation of mucus adhesion
across several C. difficile strains, and adhesion to mucins derived from different sources.
Finally, Chapter 3 describes the possible role of inter-microbial competition between
mucus-associated microbes in modulating the attachment of C. difficile to mucus.

vi

TABLE OF CONTENTS

ACKNOWLEDGMENTS ................................................................................................ iii
PREFACE ..................................................................................................................... v
TABLE OF CONTENTS.................................................................................................. vi
CHAPTER ONE: LITERATURE REVIEW................................................................ 1
1.1

CLOSTRIDIOIDES DIFFICILE: A NOSOCOMIAL GUT PATHOGEN ..............1

1.2 MECHANISMS OF COLONIZATION AND DISEASE PROGRESSION .................1
1.2.1 Spore transmission and germination .........................................................................1
1.2.2 Colonization resistance: protection by resident gut flora ..........................................2
1.2.3 Toxin production and sporulation.............................................................................4
1.2.4 Adherence to the gut mucosa ....................................................................................5
1.2.5 Association with mucus layer ....................................................................................7
1.3 TOOLS FOR STUDYING C. DIFFICILE ADHESION TO MUCUS IN VITRO.........9
1.4 PUTATIVE ADHESINS MEDIATING HOST-MICROBE INTERACTIONS
DURING CDI ................................................................................................................. 11
1.4.1 Flagella and colonization......................................................................................... 14
1.4.2 Type IV pili and colonization .................................................................................. 15
1.5 CONCLUSIONS ....................................................................................................... 16
1.6 REFERENCES .......................................................................................................... 18

CHAPTER TWO: INVESTIGATION OF C. DIFFICILE COLONIZATION
FACTORS NECESSARY FOR IN VITRO ADHERENCE TO AN ARTIFICIAL
MUCUS LAYER ...................................................................................................... 30
2.1 ABSTRACT .............................................................................................................. 30
2.2 INTRODUCTION .....................................................................................................31
2.3 MATERIALS AND METHODS ................................................................................ 33
2.3.1 Bacterial strains and growth conditions ..................................................................33
2.3.2 Preparation of artificial mucosal surface ................................................................ 34
2.3.3 Commercial porcine stomach mucin partial purification ........................................ 34
2.3.4 Extraction and purification of porcine colonic mucin ............................................. 35

vii
2.3.5 Fluorescently labeled C. difficile.............................................................................. 36
2.3.6 Mucosal adhesion assay .......................................................................................... 36
2.3.7 Swimming motility assay......................................................................................... 37
2.3.8 6xHis-FliD expression and purification ...................................................................37
2.3.9 Competitive exclusion assay .................................................................................... 39
2.3.10 Statistical analyses ................................................................................................ 39
2.4 RESULTS .................................................................................................................. 39
2.4.1 Covalent immobilization of mucins as an in vitro mucus layer model...................... 39
2.4.2 C. difficile preferentially adheres to mucus ............................................................. 42
2.4.3 A C. difficile R20291 fliC mutant is deficient in in vitro adherence to mucus ........... 44
2.4.4 C. difficile R20291 fliC mutant is deficient in swimming motility ............................ 46
2.4.5 Competitive exclusion of microbe-mucus interactions by protein blocking ............. 47
2.4.6 Swimming motility and mucus adherence vary by strain ........................................ 50
2.4.7 Structural features of mucin impact in vitro adherence........................................... 51
2.5 DISCUSSION ............................................................................................................ 52
2.6 REFERENCES .......................................................................................................... 56

CHAPTER THREE: MUCIN ENZYMATIC MODIFICATION BY PRIMARY
DEGRADERS ALTERS C. DIFFICILE ADHERENCE ........................................... 65
3.1 ABSTRACT .............................................................................................................. 65
3.2 INTRODUCTION .....................................................................................................65
3.3 MATERIALS AND METHODS ................................................................................ 68
3.3.1 Bacterial strains and growth conditions ..................................................................68
3.3.2 Biological mucin modification by live primary degraders ....................................... 68
3.3.3 Sialidase activity of cell-free supernatants .............................................................. 69
3.3.4 Biological mucin modification by cell-free supernatant........................................... 70
3.4 RESULTS .................................................................................................................. 71
3.4.1 R. gnavus and B. thetaiotaomicron decrease mucosal adherence by C. difficile ........ 71
3.4.2 Sialidase activity of cell-free supernatants from primary degraders ....................... 71
3.5 DISCUSSION ............................................................................................................ 73
3.6 REFERENCES .......................................................................................................... 75

viii

LIST OF TABLES
Table 1. Summary of putative C. difficile adhesins previously
investigated .......................................................................................... 12-13

ix

List of Figures
Figure
Page
1.1 Structure of the colonic mucus layer ....................................................6
2.1 Establishment of an in vitro model of direct mucus adherence by
C. difficile ..................................................................................................42
2.2 C. difficile preferentially adheres to mucin O-linked glycans in
vitro ............................................................................................................44
2.3 Role of T4P and flagella in mediating adhesion of C. difficile to
mucus .........................................................................................................46
2.4 A C. difficile fliC mutant strain is deficient swimming motility.... 47-48
2.5 FliD(67-507) blocking does not impact C. difficile adherence to
mucus .........................................................................................................50
2.6 Comparison of swimming motility and mucus attachment across
multiple C. difficile strains .........................................................................52
2.7 Structural and chemical features of mucin facilitate attachment .........53
3.1 Primary mucin degrading bacteria influence C. difficile adherence to
mucin..........................................................................................................73

CHAPTER ONE: LITERATURE REVIEW

1.1 CLOSTRIDIOIDES DIFFICILE: A NOSOCOMIAL GUT PATHOGEN
Clostridioides difficile (recently reclassified from Clostridium difficile (Lawson et
al., 2016)) is an opportunistic, spore-forming pathogen capable of causing
gastrointestinal illness. Disease severity ranges from mild, self-limiting diarrhea to lifethreatening pseudomembranous colitis or toxic megacolon. Recent emergence of
hypervirulent clinical isolates with increased antibiotic resistance and rates of disease
recurrence has led the United States Centers for Disease Control and Prevention (CDC)
to classify C. difficile

(Fatima & Aziz, 2019).

Even so, rates of community transmission continue to rise (Durovic et al., 2018). More
research into C. difficile pathogenesis and disease mechanisms is needed to develop novel
prevention strategies and precision therapeutics. In this review, I will briefly highlight the
pathogenic strategy of C. difficile, discuss general mechanisms of gastrointestinal
colonization and persistence, and provide direction for future investigation into C.
difficile

1.2 MECHANISMS OF COLONIZATION AND DISEASE PROGRESSION
1.2.1 Spore transmission and germination
As an anaerobic bacterium, vegetative C. difficile cells are unable to survive the
aerobic environment outside the host (Zhu et al., 2018). Fecal-oral transmission of
dormant spores between hosts is therefore a key aspect of C. difficile pathogenesis. The
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protective coating of spores allows them to persist on surfaces and in the soil for months
and sometimes years. Potential reservoirs of infectious spores include asymptomatic
carriers, infected patients, livestock or animal intestinal tracts, and contamination in the
environment (Czepiel et al., 2019). In addition to oxygen, spores are resistant to ethanol,
hydrogen peroxide, chloroform, and heat, greatly limiting the effectiveness of
decontamination efforts (Edwards, Karim, et al., 2016; Gil et al., 2017).
Following ingestion by the host, C. difficile spores transit the gastrointestinal tract
(GIT), experiencing no apparent loss in viability after exposure to digestive enzymes
(Escobar-Cortés et al., 2013). Although spores are considered metabolically dormant,
they still respond to signaling in the intestinal environment for germination-inducing
small molecules known as germinants (Shrestha et al., 2019). These small molecules are
species specific despite significant conservation of endospore structure across endosporeforming bacteria. In the case of CDI, a few important germinants include bile acids in
combination with specific amino acids (Howerton et al., 2011; Shrestha & Sorg, 2018).
One mechanism by which the natural gut microbiota provides protection against C.
difficile germination is through the conversion of primary conjugated bile acids to
unconjugated primary and secondary bile acids which are less effective at promoting
germination, and sometimes even inhibitory (Theriot et al., 2016). Like other forms of
colonization resistance, microbial bile acid conversion can be greatly diminished because
of antibiotic therapy, aging, and immune deficiency.

1.2.2 Colonization resistance: protection by resident gut flora
Beyond regulating levels of primary and secondary bile acids, the resident gut
flora provides additional forms of colonization resistance against C. difficile. Other
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nutrient sources or metabolites can be converted to inhibitory molecules that impact
vegetative cell proliferation or the ability of spores to germinate. There can also be direct
competition for nutrients between C. difficile and other microbes. For example, the
availability of different carbon sources and the way in which they are metabolized by C.
difficile has been shown to greatly influence toxin production, likely playing a key role in
mediating the progression of CDI (Neumann-Schaal et al., 2015).
The availability of dietary and host-derived carbohydrates in the colon is known
to greatly influence gut microbial diversity and therefore protection against CDI. It was
recently shown that C. difficile is able to cross-feed and catabolize mucin-derived glycans
following enzymatic liberation by other gut bacteria (Engevik et al., 2020). By
controlling access to host-derived nutrients, the abundance of primary mucin degrading
species may modulate C. difficile
microbes can also influence host immunity, production of antimicrobial peptides, and
mucus production, which collectively provide a barrier to colonization by C. difficile
(Britton & Young, 2014).
Developing a better understanding of the nutrient niche filled by C. difficile and
its role in colonization resistance may offer promising alternative therapeutic strategies.
For example, it was recently demonstrated that pre-colonization of hamsters with nontoxigenic strains of C. difficile was capable of protecting against disease following
successive challenge with toxigenic C. difficile (Gerding et al., 2018). Recent work from
Leslie and colleagues investigating the possible mechanisms underlying this conferred
protection found that a reduction in intestinal glycine levels and decreased ability for the
second strain to germinate may be responsible (Leslie et al., 2021). Future work is
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needed to understand the direct role of specific antibiotics in driving the metabolic and
ecological shifts which abrogate colonization resistance and promote disease.

1.2.3 Toxin production and sporulation
Following germination and subsequent stages of outgrowth, vegetative cells in the
GIT eventually encounter cellular stress which leads to toxin production and spore
formation. Although little is known about the regulation of sporulation,
repress motility and toxin production, suggesting that regulation of these phenotypes may
be related (Edwards, Tamayo, et al., 2016). The three major toxins produced by C.
difficile include TcdA, TcdB, and CDT, also known as binary toxin (Aktories et al.,
2017). Following secretion, TcdA and TcdB glucosylate small GTP-binding proteins and
contribute to disease progression by disrupting tight junctions in the intestinal epithelium,
inhibiting actin polymerization, and promoting apoptosis (Di Bella et al., 2016; Voth &
Ballard, 2005). Interestingly, CDT promotes the formation of microtubule protrusions at
the surface of intestinal epithelial cells, increasing adherence of C. difficile (Schwan et
al., 2009). Anti-toxin and vaccine therapies have been developed over the last two
decades, but they do not prevent colonization or destroy spores (Zhu et al., 2018).
Therapeutics which accomplish these goals and protect against the possibility of
relapsing CDI should therefore be a primary focus of future investigations.
Although studies focused on C. difficile sporulation and toxin production have
revealed their important contributions to CDI, little is known about the role of C.
difficile adherence to the host. Furthermore, TcdA and TcdB are thought to be essential
for disease development, but are not required for colonization in humans or animals
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(Kuehne et al., 2011). For many different enteric pathogens, adherence to the host
mucosa is a known requirement for colonization of the GIT and disease progression.
Developing an understanding of the genetic and molecular basis for mucosal adherence
by C. difficile may therefore provide context for mechanisms underlying colonization and
persistence during CDI.

1.2.4 Adherence to the gut mucosa
It has been widely demonstrated that adherence to host tissues is a prerequisite for
colonization and expression of virulence factors for many enteric pathogens. For
example, adherence to the host mucosa is considered to be essential for infection and
disease caused by Helicobacter pylori (Testerman et al., 2014) and Campylobacter jejuni
(Konkel et al., 2010). Vegetative C. difficile cells are known to colonize the colon during
human CDI; colonization of other human bodily sites, including the small intestine, is
considered rare (Heinlen & Ballard, 2010). While the colon has been identified as a
primary site of colonization, mechanisms underlying host adherence by C. difficile are
not completely understood. Collective evidence from several previous studies suggest
that adherence may be relevant for CDI and should be further probed.
An early study investigating colonization of hamsters by C. difficile found that a
virulent, toxigenic strain had greater adherence to the gut mucosa than both a less virulent
toxigenic strain and a non-toxigenic strain (Borriello et al., 1988). These findings
provided preliminary evidence that adherence might determine virulence, but a lack of
strain diversity limited formation of such broad conclusions. Later work by another group
compared the adherence of 12 different isolates of C. difficile in a murine model of
infection, finding that toxigenic strains had greater in vivo mucosal adherence than non-
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toxigenic strains (Gomez-Trevino et al., 1996). Several years later, a separate study
observed no difference in in vitro adherence between toxigenic and non-toxigenic strains
to Vero cells (Anne Judith Waligora et al., 1999). One possible reason for these
conflicting findings may stem from the use of Vero cells to model adherence to the
intestinal epithelium. Vero cells are derived from the kidney of an African green monkey
(Ammerman et al., 2008)
to those expressed by intestinal epithelial cells.
In addition to receptors on the surface of epithelial cells, the luminally exposed
protective outer mucus layer and extracellular matrix (ECM) offer potential receptor
binding sites for intestinal microbes (Figure 1.1). If these constituents do in fact contain
binding sites that are important for C. difficile attachment, this would also help explain
conflicting findings in the literature. In fact, evidence suggesting C. difficile adheres to
mucus has existed in the literature for several decades. Recognizing that mucosal
adherence may be a determinant for virulence, Karjalainen and colleagues were interested
in identifying a possible bacterial adhesin which could mediate attachment (Karjalainen
et al., 1994). A surface protein found to be upregulated following heat-shock and
hypothesized to mediate adherence was recombinantly expressed and purified. The 27kDa hypothetical adhesin adhered to Caco-2 and Vero cells, but this interaction was
diminished by co-incubation with axenic murine mucus or N-acetylgalactosamine, a
mucus glycan. This was one of the earliest examples of indirect evidence suggesting that
C. difficile possesses surface proteins which bind mucus or its glycan components.
Despite the significance of these findings, the relevance of possible C. difficile adherence
to mucus during CDI is largely unknown as many investigations have focused on
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adherence to epithelial cells. Studies from the last decade have renewed interest in
microbe-mucus interactions during CDI.

Figure 1.1 Structure of the colonic mucus layer. The colonic mucus layer consists of a
firm, adherent inner mucus layer and a loose, outer mucus layer. The most abundant
colonic mucin, MUC2, is secreted by goblet cells (green) in the epithelium. O-linked
glycans on the surface of mucins provide attachment sites and nutrients for mucusassociated microbes in the outer mucus layer while microbes are typically excluded from
the inner layer under healthy conditions. (This figure was created under a paid
subscription to Biorender.com)

1.2.5 Association with mucus layer
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The mucus layer has unique physical and chemical properties that cause it to
compress rapidly under desiccating ex vivo conditions such as exposure of excised tissue
sections to the open air. Additionally, fixation of tissue sections by conventional crosslinking agents causes complete mucus layer compression, limiting our understanding of
its architecture and microbial composition (Johansson et al., 2011). However, tissue
ation
of mucus structure (Hasegawa et al., 2017; Swidsinski et al., 2005) and microscopic
observation of bacterial species localized to this region of the mucosa. Recently, C.
difficile was found to associate with the loose outer mucus layer of the cecum and colon
in a murine model of infection (Semenyuk et al., 2015). In contrast to work from other
groups, Semenyuk and colleagues found no evidence of colonization or attachment to
epithelial cells, suggesting preferential colonization of the murine mucus layer by C.
difficile.
Although ethical conflicts prohibit researchers from directly evaluating C.
difficile
compelling evidence that microbe-mucus interactions, including attachment, are relevant
to human CDI. For example, CDI patients were reported to have decreased MUC2 mucin
expression relative to healthy subjects (Engevik et al., 2015). MUC2 is the most abundant
mucin glycoprotein in the human colon (Johansson et al., 2011a) and contains many
receptors important for colonization by mucus-associated bacterial species. Altered
mucin expression in CDI patients could therefore plausibly impact availability of binding
sites for C. difficile, greatly influencing virulence and disease severity.
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In the same study by Engevik and colleagues, C. difficile alone was capable of
decreasing MUC2 expression in an infection model using human intestinal organoids
(Engevik et al., 2015). Additionally, using mucus extracted from CDI and healthy patient
stools, C. difficile was found to preferentially adhere to CDI patient mucus (Engevik et
al., 2015). A later study also reported preferential in vitro adherence to mucus from
mucus-secreting human intestinal epithetical cell lines (Engevik et al., 2020). Observed
differences in mucin gene expression and relative C. difficile adhesion between healthy
and infected populations suggest that further investigation of microbe-mucus interactions
may elucidate novel targets for therapeutic development in the treatment of CDI.

1.3 TOOLS FOR STUDYING C. DIFFICILE ADHESION TO MUCUS IN
VITRO

Because attachment to the host is considered essential for numerous enteric
pathogens and commensals, many in vitro models of adhesion to the GIT mucus layer
have been developed. The most commonly used method involves passive immobilization
of mucus onto 96-well polystyrene plates by overnight incubation at 4°C (Cohen & Laux,
1995). The main advantage of this method is the simplicity of immobilization and that

interactions with mucus can be isolated. Hydrophobic interactions with polystyrene can
be a problem, however, and background bacterial adherence to plastic wells has been
shown to account for a significant amount of detected adhesion (Laparra & Sanz, 2009).
This may limit the application of in vitro findings to host attachment during CDI in vivo.
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Adherence to tissue culture cells is another common investigative approach. For
enteric bacteria, Caco-2 and HT-29 human intestinal epithelial cell lines are most
commonly used. Cell surface factors important for bacterial adherence are incorporated
into this model making it a better representation of in vivo conditions. However, Caco-2
and HT-29 cell line models do not account for the intestinal mucus layer (van Tassell &
Miller, 2011) and are derived from cancer cells, so they may not be representative of
healthy tissue. HT-29 MTX cells secrete high levels of mucins and can be used to
incorporate a mucus layer into adhesion studies, though they also are not representative
of healthy tissue or mucin glycosylation. Furthermore, models utilizing a single cell type

incorporate cell lines representative of both enterocytes and goblet cells into a single
monolayer have been used to study drug absorption, and would likely provide utility in
studying adhesion of gut pathogens and commensals (Béduneau et al., 2014; Hilgendorf
et al., 2000; Pan et al., 2015).
Finally, tissue sections from healthy digestive tracts can be used for in vitro
adhesion assays. While human gastrointestinal tissue sections can be difficult to obtain,
tock and other animals. In the case of gut pathogens
like C. difficile which are known to infect humans and animals (Weese, 2020), tissue
sections from multiple hosts would be desirable for evaluation of possible strain or
ribotype adaptation. Adhesion to tissue sections is likely to be most representative of in
vivo conditions, particularly due to the incorporation of competitive exclusion by the
naturally occurring GIT flora (van Tassell & Miller, 2011). However, as with the cell
culture models, direct microbe-mucus interactions can be difficult to distinguish from
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microbial adhesion to other cell-surface factors. Therefore, if investigation of specific
adhesion to mucus is desirable, reducing the complexity of the in vitro model used may
be desirable prior to use of tissue sections.

1.4 PUTATIVE ADHESINS MEDIATING HOST-MICROBE
INTERACTIONS DURING CDI
Building on the early studies highlighting the importance of GIT adherence to
CDI, more recent studies have focused on characterizing different spore and cell-surface
proteins as putative adhesins (Table 1). While many studies have investigated C.
difficile
their relative importance. A major reason why conclusions cannot be drawn lies in the
lack of standardization of in vitro and in vivo adhesion models across studies. For
example, prior studies attempting to model adhesion in vitro have used many different
cell lines, including Caco-2, Vero, Hep-2, HT-29, and MDCK cells. Some of these cell
lines are not derived from the intestinal epithelium and are less than ideal for modeling
GIT adherence. Furthermore, differences in media used during the adhesion stage of the
assay, inoculum concentration/growth stage, length of incubation, washing steps, and
other experimental parameters likely influence results. Despite these limitations, results
from previous studies are still important and can be used to guide the development of
future investigations. Due to available access to C. difficile R20291 type IV pili and
flagellar mutants in the Piepenbrink lab, our investigation focuses on characterizing the
putative role of these appendages in mediating adhesion to mucus. Other putative
adhesins are beyond the scope of this work but have been included in Table 1 for
reference and future investigations.
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Table 1. Summary of putative C. difficile adhesins previously investigated.
Experimental
Model

Putative
Adhesin

Cd Genetic
Background

Results

Reference

Caco-2 Cells

Spore
Surface
Proteins

630

Two 40-45 kDA spore-specific
proteins mediate adherence to
Caco-2 monolayers

(Paredes-Sabja
& Sarker, 2012)

79-685

Polyclonal antibodies to Cwp66-N
and Cwp66-C and Cwp66N/Cwp66-C protein
recombinant proteins inhibited
Vero cell adherence

(A. J. Waligora
et al., 2001)

(C. Hennequin
et al., 2001)

Vero Cells

Cwp66

Vero Cells

GroEL
(Hsp60)

79-685

Polyclonal GroEL-specific
antibodies and recombinant
GroEL inhibited Vero cell
adherence

Dot Blotting
& C3H Mice

FliC and
FliD

79-685
ATCC 43593
EX560
ATCC 43598
6058

Recombinant FliC, FliD, and
crude flagella adhered to axenic
mouse cecal mucus in vitro;
Flagellated strains were
significantly more adherent to the
mouse cecum than non-flagellated
strains in vivo

(Tasteyre et al.,
2001b)

Hep-2 Cells &
Mouse Colon
Tissue
Sections

Surface
Layer
Proteins
(SLPs)

1
17
630

Native and recombinant HighMW SLPs bound to Hep-2 cells
and mouse colon tissue; Low-MW
SLPs did not bind as efficiently

(Calabi et al.,
2002)

Fibronectin &
Vero Cells

Fbp68
(FbpA)

79-685

FbpA-specific antibodies inhibited
adherence to fibronectin and Vero
cells

(Claire
Hennequin et
al., 2003)

Caco-2/HT-29
MTX Cells,
Mono- and
dixenic mice,
HMA mice

Caco-2 Cells
& Hamster

FbpA

mutant had increased
adherence to Caco-2/HT-29MTX
cells; Colonization of the cecal

(Barketi-Klai et
al., 2011)

mutant in monoxenic mouse but
not in dixenic or HMA model

FliC and
FliD

FliC and FliD mutants had
increased adherence to Caco-2
cells; Flagellar mutants were more
virulent in hamster model of
infection

(Dingle et al.,
2011)
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Caco-2 BBE
Cells

Caco-2 Cells,
C3H and HeN
Germ-free or
HMA Mice

SlpA

FliC and
FliD

CbpA

Caco-2 Cells

Lipoprotein
CD0873

Caco-2 Cells

Crude and purified SlpA subunits
and SlpA antisera inhibited
adherence to Caco-2 BBE cells
R20291 flagellar mutants (FliC
and FliD) had decreased
adherence to Caco-2 cells while

R20291

(Merrigan et al.,
2013)

(Baban et al.,
2013)

flagellum important for R20291
adherence in vitro and in vivo

Collagen V,
IMR-90 Cells

HT-29/Caco2/MDCK
Cells
C57BL/6
Mice

36 Clinical
Isolates
(epidemic and
non-)

CbpA mutant showed no defect
in adherence to collagen V or
IMR-90 cells; CbpA-expressing
L. lactis had increased adherence
to collagen V

deficiency in adherence to Caco-2
cells; Antibodies against CD0873
inhibited adherence

(Tulli et al.,
2013)

(Kovacs-Simon
et al., 2014)

PilA1

TFP important for prolonged
adherence to epithelial cells in
vitro; TFP-null strains had
reduced adherence to cecal
mucosa in murine infection model

(Mckee et al.,
2018)

Cwp66

Cwp66 mutant had decreased
adherence to Caco-2 cells;
Restored WT adhesion through
plasmid-complementation of
Cwp66

(Zhou et al.,
2022)

630
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1.4.1 Flagella and colonization
The most well-studied colonization factor of C. difficile is the flagellum.
Flagellum-mediated motility enhances the ability of pathogenic bacteria to move towards
an initial site of colonization, but flagella also function as direct adhesins in a number of
enteric species (Friedlander et al., 2013; Haiko & Westerlund-Wikström, 2013). One
early study focused on the role of flagella in mediating C. difficile
recombinant FliC and FliD (flagellin or flagellar-cap, respectively) as well as crude
flagella displayed binding to cecal mucus from axenic mice (Tasteyre et al., 2001a). Even
though C. difficile (including human clinical isolates) is known to cause disease in swine
(Steele et al., 2010), these proteins did not bind to porcine gastric mucin. Because tools
for genetic manipulation of C. difficile were limited at the time, Tasteyre and colleagues
attempted to validate their in vitro findings in an axenic mouse model utilizing flagellated
and non-flagellated strains from the same serotype. While this indirect approach limits
the strength of experimental conclusions, non-flagellated strains had significantly less
cecal adherence than flagellated suggesting that flagella may be important for CDI in
vivo.
Today, ClosTron mutagenesis (Heap et al., 2007) and other genetic techniques
enable researchers to directly evaluate the role of specific proteins in C. difficile
pathogenic strategy, including attachment and colonization. Gene interruption mutants of
fliC or fliD

C. difficile were non-flagellated and had increased

adherence to intestinal Caco-2 tissue culture cells relative to the wild-type strain (Dingle
et al., 2011). Wild-type levels of adhesion were restored upon complementation of fliC
and fliD encoded on a plasmid. In the same study, flagellar mutant and complement
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results might lead to the conclusion that flagella are not important for colonization, but
differences in toxin production between mutant and parental strains and the overall
extreme sensitivity of hamsters to TcdA and TcdB make the in vivo results difficult to
interpret (Libby et al., 1982).
While results from Dingle and colleagues were duplicated by another group in a
later study (Baban et al., 2013), findings were not consistent across different strains of C.
difficile. Baban and colleagues found that gene interruption mutants of fliC or fliD in the
hypervirulent epidemic R20291 strain had reduced adherence to Caco-2 tissue culture
cells relative to the R20291 wild-type strain. In the same study, the fliC and fliD mutants
also had reduced adherence to Caco-2 cells relative to a motB mutant, which possessed a
paralyzed flagella. Furthermore, the motB mutant had higher relative colonization and
cecal adherence than the fliC mutant in murine co-challenge experiments. Based on these
results, the authors concluded that flagellum-mediated motility is not required for
colonization and that the flagellum itself may function as an adhesin. Recently it was
suggested that the observed phenotypic differences between the epidemic R20291 strain
and the noneach strain to phase vary flagellar production (Mckee et al., 2018).

1.4.2 Type IV pili and colonization
Another extracellular proteinaceous fiber which may play a role in C. difficile
colonization is type IV pili (T4P). T4P are polymers of a major pilin protein (PilA1 in C.
difficile) and have functions in adhesive processes such as microcolony formation, DNA
uptake, and adherence to eukaryotic cells (Melville & Craig, 2013; Piepenbrink et al.,
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2015). T4P promote early biofilm formation in C. difficile in vitro (Maldarelli et al.,
2016) and were found to be contained in the core genome during microarray analysis of
74 isolates, suggesting they are likely indispensable for CDI in humans (Stabler et al.,
2006). Because T4P serve a wide array of functions in different bacterial systems, there
are several possible mechanisms by which they could mediate adherence. For example,
they could mediate direct adhesion to host cells, simply promote microcolony formation
and resistance to peristaltic removal, or promote invasion of epithelial cells (McKee et
al., 2018).
Beyond their role in promoting early in vitro biofilm formation, little is known
about these versatile appendages in C. difficile. A non-piliated pilA1 mutant in C. difficile
had no observable differences in adherence to HT-29 cells after one hour
relative to the parental strain (McKee et al., 2018). However, the same pilA1 mutant was
deficient in adherence to MDCK cells after 24 hours relative to the parental strain,
suggesting that T4P may be unnecessary for initial attachment to host cells but necessary
hen
investigating the role of T4P in adherence and colonization. As previously mentioned
with flagella, investigation of T4P in multiple strains of C. difficile is also necessary
before any major conclusions can be drawn.

1.5 CONCLUSIONS
The emergence of hypervirulent C. difficile strains and increasing rates of
community transmission necessitate development of novel therapeutics and precision
treatment options for CDI. Combined evidence from early and recent studies provide
support for mucus as a possible site of attachment and colonization by C. difficile during
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in vivo infection. Preventing or diminishing adhesion to mucus or the metabolic
substrates it provides to C. difficile may therefore offer new options for therapeutic
targets. A greater understanding of the molecular mechanisms underlying initial mucosal
colonization and persistence in the GIT are needed before such therapeutics can be
developed. Many different surface proteins have been demonstrated to mediate adherence
in vitro and in vivo
infection. Beyond the colonization factors found on the surface of vegetative cells and
spores, it will be important to consider C. difficile colonization in the ecological context
of a complex, adaptive microbial community and host immune system.
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CHAPTER TWO: INVESTIGATION OF C. DIFFICILE
COLONIZATION FACTORS NECESSARY FOR IN VITRO
ADHERENCE TO AN ARTIFICIAL MUCUS LAYER

2.1 ABSTRACT
Clostridioides difficile is a Gram-positive, spore-forming anaerobe and is the most
common cause of antibiotic-associated diarrhea, representing a major public health threat.
Although intestinal dysbiosis and immune deficiency are known to favor Clostridioides
difficile infection, the underlying host-pathogen interactions that promote colonization
and persistence in humans are unknown. Recent in vitro and animal studies have
provided compelling evidence that C. difficile associates with the colonic mucus layer
during infection creating interest in investigating mucus as a putative site of colonization.
Using an improved quantitative model of in vitro adherence to mucus, we explored the
molecular mechanisms underlying association with mucus. Specifically, we explored the
potential for extracellular appendages, Type IV pili (T4P) and flagella, to mediate
mucosal adherence. Using immobilized mucins and gene-interruption mutants of the
primary T4P (pilA1) and flagellar (fliC) subunits, flagella were found to be important for
adhesion while T4P were not necessary. Through chemical modification of an in vitro
mucus layer, we also observed that O-linked glycans facilitate adhesion. Finally, by
comparing multiple strains of C. difficile and mucins derived from human and animal
origin, we observed the ability of mucin structural and chemical variation to impact C.
difficile attachment with possible implications for insights into host tropism.
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2.2 INTRODUCTION
Clostridioides difficile is a Gram-positive, spore-forming, obligate anaerobe and
was the most common healthcare-associated infection prior to recently being surpassed
by SARS-CoV-2 (Khanna & Kraft, 2021). Disease severity ranges from mild, selflimiting diarrhea to life-threatening pseudomembranous colitis and toxic megacolon.
Recent emergence of hypervirulent clinical isolates with increased antibiotic resistance
and rates of disease recurrence has led the United States Centers for Disease Control and
Prevention (CDC) to classify C. difficile
(Fatima & Aziz, 2019). Data from the last decade also shows that roughly 40% of C.
difficile infections in the United States are community-associated cases which often do
not involve predisposing antibiotic use or hospitalization (Khanna et al., 2012). To
identify novel therapeutic targets for CDI, investigations of the molecular mechanisms
which enable C. difficile to colonize and persist in the gut are necessary.
Logically, attachment to host mucosal surfaces allows both pathogens and
commensals to increase time of intestinal residence and associate with regions of the
digestive tract harboring a favorable ecological niche (Adlerberth et al., 2000). It is
therefore possible that host attachment and colonization of the gut mucosa may be
important to the pathogenic strategy of C. difficile. Numerous early in vitro studies (See
Table 1.1) have yielded conflicting results for the role of molecular colonization factors
(CFs) in adherence to intestinal epithelial cell lines. However, recent studies have
provided some evidence that C. difficile associates with the mucus layer during infection
(Engevik, Danhof, et al., 2020a; Engevik, Engevik, et al., 2020; Semenyuk et al., 2015a).
Therefore, some of the previously explored CFs may be essential for adherence to the
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gastrointestinal mucus layer and yet unessential for adherence to commonly used cell
lines which do not produce a mucus layer.
Type IV pili (T4P) and flagella have been implicated as adhesive appendages in
numerous commensal and pathogenic bacteria (Carbonnelle et al., 2006; Melican et al.,
2013; Piepenbrink & Sundberg, 2016; Xicohtencatl-Cortes et al., 2007) and have been
specifically suggested to promote C. difficile

in

vitro (McKee et al., 2018). Investigation of these appendages directly mediating
adherence to the mucus layer are limited and often conflicting. A main objective of this
work was therefore to compare the relative adherence of C. difficile R20291 T4P and
flagellar mutants to immobilized mucus. Importantly, the adhesion assay model chosen
has the advantages of directly investigating microbe-mucus interactions while preventing
interference from non-specific adhesion caused by hydrophobic interactions.
In parallel with identification of the CFs which mediate adherence, investigation
of the structural features of the mucus layer which serve as potential adhesin receptor
sites is necessary. The mucus layer which lines the GIT is principally composed of
mucin, a glycoprotein containing a protein core which is heavily O-glycosylated. Glycans
account for approximately 80% of the mass of mucin molecules and influence the
functional properties of mucus like viscoelasticity and gel-formation (Naughton et al.,
2014). There are at least 17 different mucin families in humans, composed of both
membrane-bound and secreted mucins (Juge, 2012; Voynow & Fischer, 2006). MUC1,
MUC5AC, and MUC6 predominate in the stomach while secreted MUC2 mucin is most
abundant in the small intestine and colon (Juge, 2012).
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Differences in mucin expression and glycosylation between bodily sites, different
individuals, healthy and diseased tissues, and different hosts represent a wide diversity of
bacterial receptors and nutrients which could explain some of the bacterial-host tropism
observed in nature (Adlerberth et al., 2000). C. difficile is known to infect a wide range of
hosts including pigs, cattle, horses, dogs, and other animals (Gould & Limbago, 2010;
Knight & Riley, 2019; Rabold et al., 2018). By using human and animal-derived bacterial
isolates in combination with gastrointestinal mucus from different hosts, an additional
objective of this work was to investigate preferences in adherence to structurally-varied
mucins, providing preliminary insights into possible specificity for mucus receptors and
evolutionary adaption for mucus attachment by vegetative C. difficile.

2.3 MATERIALS AND METHODS
2.3.1 Bacterial strains and growth conditions
C. difficile 630, R20291, pilus, and flagellar mutants were a generous gift from
015, and
VPIUniversity of Nebraska-Lincoln.
Overnight cultures of C. difficile were grown from frozen glycerol stocks on
BHIS(TA) agar plates (37 g/L RPI brain heart infusion broth, 0.5% yeast extract, 0.1% Lcysteine, 0.1% sodium taurocholate) at 37°C in an anaerobic chamber (Coy Lab
Products) with an atmosphere of 5% H2, 5% CO2, and 90% N2. Thiamphenicol (15
g/mL) or lincomycin (20 g/mL) were added for mutant strains as necessary.
Cycloserine-cefoxitin-fructose agar supplemented with 0.1% sodium taurocholate
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(TCCFA) selective media was used periodically, as previously described (Sorg &
Dineen, 2009). For experiments, individual colonies from overnight plates were used to
inoculate BHIS(TA) broth with appropriate antibiotics, unless otherwise specified.
2.3.2 Preparation of artificial mucosal surface
LS174T/HT-29 MTX human epithelial cell-derived mucins or partially purified
porcine stomach mucins were covalently immobilized on glass coverslips (Engevik et al.,
2020; Landry et al. , 2006). Coverslips were washed in 1 M HCl overnight at 60°C.
Clean coverslips were washed in sterile deionized water, then autoclaved. Once dry,
coverslips were transferred to a 4% solution of (3-aminopropyl)triethoxysilane (Sigma
#440140) in acetone for one hour, washed with acetone (Fisher), then heat treated at
110°C for one hour. Terminal aldehydes were formed on the surface by incubating the
coverslips in 2.5% aqueous glutaraldehyde (v/v) (Fisher) for one hour and rinsing with
water. Finally, coverslips were incubated in 1 mg/mL PBS-mucin overnight at 4°C.
Coverslips were air-dried and UV-treated for sterility, then stored at 4°C.
2.3.3 Partial purification of commercial porcine stomach mucin
Commercial porcine stomach mucin (Sigma #M1778) was partially purified prior
to use (Beighton et al., 1988; Gargano et al. , 2014). Crude mucin was suspended at
approximately 20 mg/mL in 0.1M NaCl. The pH was adjusted to 7.0 and the solution was
stirred overnight at 4°C. The following day, insoluble residues were pelleted by
centrifugation (10,000 x g for 10 min.). Mucin contained in the supernatant was
precipitated in ice cold 60% ethanol (v/v), then recovered by centrifugation (10,000 x g
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for 10 min.). Dissolving and precipitation steps were repeated twice more. The final
pellet was resuspended in 0.1 M NaCl pH 7.0 and stored at -80°C.
2.3.4 Extraction and purification of porcine colonic mucin
Porcine colonic mucin was purified from pig digestive tracts obtained from the
University of Nebraska-Lincoln Department of Animal Science. Colonic mucosal tissue
samples were prepared by gentle scraping of the mucosa with glass coverslips. Samples
were stored at -80°C until further processing.
Extraction and purification of mucins was performed similar to previously
described methods (Asker et al., 1995; Carlstedt et al., 1983). Briefly, mucosal tissue
samples were suspend in extraction buffer (6 M guanidium chloride, 5 mM EDTA, 0.01
M NaH2PO4, 100 mM PMSF, pH 6.5) and homogenized, then stirred overnight at 4°C.
The insoluble fraction containing mucins was removed by centrifugation using a JA-20
rotor (18,000 rpm, 10°C, 30 min.). The resulting pellet was resuspended in extraction
buffer and the process was repeated 3 times, limiting stir durations to 2-3 hours for
remaining extractions.
Extracted insoluble mucins were solubilized in reduction buffer (6 M guanidium
chloride, 0.1 M Tris, 5 mM EDTA, 25 mM dithiothreitol, pH 8.0) by stirring at 37°C for
approximately 5 hours. Alkylation was performed by addition of 62.5 mM iodoacetamide
(final concentration) and the solution was stirred overnight at room temperature in the
dark. The next day, contaminant proteins were removed by centrifugation (10,000 rpm,
4°C, 30 min.) and the resulting supernatant containing soluble mucins was lyophilized.
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For experiments, mucins were resuspended in appropriate buffer at a final concentration
of 1 mg/mL unless otherwise specified.
2.3.5 Fluorescent labeling of C. difficile
For microscopy experiments, C. difficile cells were fluorescently labeled with
CFDA-SE (5(6)-carboxyfluorescein diacetate succinimidyl ester; STEMCELL
Technologies) (Engevik, Danhof, et al. , 2020). Briefly, mid-exponential phase cultures
were washed three times with anaerobic PBS by gentle centrifugation (4,500 x 5 for 6
min.). After washing, cells were incubated in anaerobic PBS containing 10 mM CFDASE at 37°C for one hour. Following incubation, excess dye was removed by three
consecutive washing and centrifugation steps as previously performed.
2.3.6 Mucosal adhesion assay
Prepared mucin-coated coverslips were used for evaluating the ability of C.
difficile R20291 to interact with an artificial mucosal surface in vitro. Individual colonies
were used to inoculate BHIS(TA) broth, and bacteria were grown to mid-log phase (4-6
hours) at 37°C. Cells were gently centrifuged (4,500 x g for 8 minutes), then resuspended
in phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8
mM KH2PO4, pH 7.4) at OD600 =2.0. Suspensions were added to sterile 6-well cell
culture plates containing mucin-coated coverslips or clean glass controls and incubated at
37°C for one or 24 hours. Following incubation, unadhered bacteria were removed by
washing 3 times with 1x PBS. Adhered bacteria were then removed by incubation with
0.25% trypsin-EDTA solution (Gibco) at 37°C for 8-10 minutes. Trypsin was neutralized
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by addition of 2 volumes BHIS(TA), then recovered bacteria were plated on BHIS(TA)
agar plates and enumerated after 24-48 hours of incubation at 37°C.
2.3.7 Swimming motility assay
To assess swimming motility, C. difficile R20291 and flagellar mutant colonies
obtained on TCCFA plates were used to inoculate BHIS(TA) broth with antibiotics added
where appropriate. Cultures were grown overnight at 37°C under anaerobic conditions. The
following day, culture tubes containing pre-reduced 0.175%-0.5xBHIS (Dingle et al.,
2011; Purcell et al., 2017) were stab inoculated with each strain. Tubes were placed in a
seal-lock bag, the bag was partially closed, and the tubes were incubated at 37°C overnight.
The next day, tubes were visually assessed for swimming motility. For strain comparison,
overnight broth cultures were used to inoculate 0.3%-0.5xBHIS agar plates and
measurements were recorded every 24 hours for 72 hours (Anjuwon-Foster et al., 2018b).
2.3.8 6xHis-FliD expression and purification
A pET-28(a) plasmid construct containing C. difficile 630 FliD (amino acid
residues 67-507) and an N-terminal 6x Hislab at Emory University. Plasmid DNA was transformed into E. coli NiCO21(DE3)
competent cells (New England BioLabs Cat No. C2529H) using the heat shock method
(Froger & Hall, 2007). Isolated colonies obtained on Luria Broth (LB) agar plates
containing kanamycin (50 mg/mL) for positive selection were cultured overnight in LB
broth at 37°C with shaking. The following day, plasmid DNA from LB broth culture
growth was extracted and purified using the Wizard Plus Minipreps DNA Purification
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System (Promega). DNA samples were Sanger sequenced (Eurofins) to confirm
accuracy.
For FliD protein expression, E. coli NiCO21(DE3) cells containing FliD(67-507)pET-28(a) were grown overnight in 300 mL of LB broth containing kanamycin at 37°C
shaking at 200 rpm. The following day, 35 mL of overnight growth was used to inoculate
each of one 6 L flasks containing LB broth supplemented with kanamycin. Cells were
grown at 37°C with shaking until reaching OD60 = 0.4-0.6, at which point induction with
0.5 mM isopropyl Beta-d-1-thiogalactopyranoside (IPTG) was performed. Following
induction, cells were grown for 24-32 additional hours at 18°C and shaking before being
harvested by centrifugation (4,700 x g; 30 min, 4°C). The resulting cell pellet was
collected and stored at -80°C until purification.
For purification, frozen cell pellets were lysed in a hot water bath from frozen.
Thawed cells were suspended in 30 mL of suspension buffer (20 mM Tris-HCl, 500 mM
sucrose, 5 mM NaEDTA, 2 mM MgCl2, 50 mM NaCl, 0.1% NaN3). 1 mL DNase (2
mg/mL), 1 mL phenylmethylsulfonyl fluoride (PMSF; 0.1M), 1 mL lysozyme (25
mg/mL), and 1 mL MgCl2 (2 M). Sodium deoxycholate and Triton-X 100 were added to
give final concentrations of 1% and 0.5%, respectively. 80 mL of lysis buffer (50 mM
Tris-HCl pH 8.3, 0.1M NaCl, 1% Triton-X, 20 mM sodium deoxycholate) was added,
and the resulting lysate was centrifuged at 20,000xg for 30 minutes at 4°C. FliD was
purified from the resulting supernatant using a nickel-NTA column on a GE Akta start.
Elution fractions were further purified by size-exclusion chromatography over a GE S200
Superdex column using a Bio-Rad NGC FPLC.
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2.3.9 Competitive exclusion assay
Adherence assays were performed following blocking of mucin-coated 96-well
polystyrene plates with recombinant flagellar proteins. Porcine colonic mucus (PCM; 1
mg/mL ) was passively immobilized in wells by overnight incubation at 4°C. The
following day, wells were washed to remove unadhered mucus, and blocking with 0, 0.1,
or 1 mg/mL protein was performed for 1 hour (Miyoshi et al., 2006). Protein solutions
were removed, wells were gently washed once, and adherence assays were performed
with colony forming units (CFU) enumeration as previously described. Recombinant
PilA1 protein (1 mg/mL) was used as a negative control.
2.3.10 Statistical analyses
All statistical analyses were performed using GraphPad Prism version 9.3.1 for
macOS (GraphPad Software, San Diego, California USA). All significance differences
were determined at p-value<0.05. Relevant statistical tests used for comparisons are
discussed in figure captions.

2.4 RESULTS
2.4.1 Covalent immobilization of mucins as an in vitro mucus layer model
The most common method of evaluating microbe-mucus interactions in vitro
involves passive immobilization of mucus onto 96-well polystyrene microtiter plates
(Cohen & Laux, 1995). In preliminary studies, 1 mg/mL partially purified porcine gastric
mucin (PGM) was incubated overnight at 4°C in a sterile high-binding 96-well plate
(Corning Costar REF# 3361). Wells containing 1 mg/mL bovine serum albumin (BSA)
or buffer alone were added as controls for non-specific binding. The next day, wells were
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washed with buffer and an adherence assay involving incubation of bacteria in treated
wells, washing to remove unadhered bacteria, and enumeration of adhered bacteria was
performed (similar to steps described in Materials and Methods). The relative adherence
of C. difficile R20291 to wells treated with BSA or buffer alone was greater than to wells
treated with PGM (Figure 2.1A). Based on the observed amount of non-specific binding
to plastic, it was determined that the commonly used 96-well plate model would not be
suitable for future adhesion studies.
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Figure 2.1 Establishment of an in vitro model of direct mucus adherence by C.
difficile. (A) 1-hour C. difficile R20291 adhesion to immobilized porcine gastric mucin
(PGM), BSA, or buffer alone in 96-well microtiter plate. (B) Schematic of covalent
immobilization of mucin molecules to glass coverslips for in vitro modeling of the
gastrointestinal mucus layer (see Materials and Methods). (C) Schematic of coverslip
transfer during in vitro mucosal adhesion assay. (D) AFM topographical phase (left) and
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3D images (right) of mucin-derivatized coverslips (top) or clean glass control (bottom).
Images were obtained on a Dimension Icon AFM (Bruker).

As an alternative method of evaluating C. difficile-mucus interactions, mucins
were covalently immobilized onto glass coverslips (Figure 2.1B). Because the model
mucus layer is adhered to the coverslip, it is possible to transfer the surface of interest to
sterile wells for direct enumeration of mucus-associated bacteria (Figure 2.1C). Mucinderivatized coverslips were analyzed using atomic force microscopy (AFM) to confirm
proper coating. As anticipated, the mucin-derivatized coverslips had a surface roughness
and topography much different than a clean glass control (Figure 2.1D), demonstrating
that mucus was surface-immobilized. Some dust particle artifacts were observed on the
clean glass slide.

2.4.2 C. difficile preferentially adheres to mucus
Following AFM confirmation of mucus coverslips, an adherence assay was
performed to determine the ability of C. difficile R20291 to associate with mucus.
Fluorescently-labeled C. difficile cells were incubated with either mucus coverslips or
clean glass coverslips. Unadhered bacteria were removed by washing, and adhered
bacteria were visualized using fluorescence microscopy. As previously reported
(Engevik, Engevik, et al., 2020), C. difficile was found to preferentially adhere to mucus
(Figure 2.2A). To quantify this adherence, a similar assay was performed with unlabelled C. difficile. Adhered bacteria were treated with trypsin for removal and
quantified by CFU enumeration. In agreement with the microscopy data, adherence to
mucus coverslips was significantly greater than adherence to glass (Figure 2.2B).
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Figure 2.2 C. difficile preferentially adheres to mucin O-linked glycans in vitro. (A)
Adherence of CFDA-SE fluorescently tagged C. difficile R20291 to LS174T mucinderivatized coverslips or clean glass control (20x EVOS AMPER4682; Scale bar = 100
mm). (B) CFU enumeration of adherence to mucin-derivatized coverslips or clean glass
control (p < 0.0001; Two-tailed unpaired t-test). (C) C. difficile R20291 adherence to
porcine gastric mucin (PGM) coated coverslips with or without O-linked glycans, or
clean glass control (n=2 coverslips; * indicates p < 0.05; Ordinary one-way ANOVA
SEM shown for B and C.

It has been previously reported that C. difficile chemotaxes towards and adheres
to human epithelial cell-derived MUC2 O-linked glycans (Engevik, Engevik, et al.,
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2020). To compare these findings in our quantitative model of adherence, PGM O-linked
glycans were removed by reductive Beta-elimination (0.5 M NaBH4, 50 mM KOH, 50°C
overnight). Coverslips were prepared using the resulting mucin protein and adherence
was measured by CFU enumeration. Indeed, adherence to intact PGM was significantly
greater than adherence to PGM without O-linked glycans (Figure 2.2C). Adherence to the
modified PGM was still greater than adherence to glass, implying either that the Betaelimination reaction was incomplete or that adhesion to other moieties like the mucin
polypeptide or N-linked glycans is also a factor.

2.4.3 A C. difficile R20291 fliC mutant is deficient in in vitro adherence to
mucus
Due to access to C. difficile R20291 T4P and flagellar mutants in the Piepenbrink
lab and the implication of these appendages in mediating colonization (see Chapter 1), we
evaluated their relative ability to adhere to mucus. C. difficile R20291, pilA1 mutant
(major pilin), fliC mutant (flagellin), and mutant complements were incubated with PGM
coverslips for 1 hour. An adhesion assay utilizing CFU enumeration was performed as
before. The non-flagellated fliC mutant adhered significantly less to mucus than the
R20291 parental strain (Figure 2.3A). This finding was consistent with the observation
that an R20291 fliC mutant was deficient in adherence to Caco-2 cells in vitro (Baban et
al., 2013). Despite T4P having a demonstrated role in attachment in several bacterial
species (Piepenbrink & Sundberg, 2016), the T4P-null pilA1 mutant was not deficient in
adherence, and in fact appeared to have increased attachment to mucus. Importantly,
trends in relative adherence obtained with PGM coverslips were conserved for coverslips
coated with HT-29 MTX human epithelial cell derived mucus (Figure 2.3B).
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Figure 2.3 Role of T4P and flagella in mediating adhesion of C. difficile to mucus.
(A) CFU enumeration of 1-hour attachment by C. difficile R20291, T4P, and flagellar
mutants to PGM (n = 3 coverslips per strain) or HT-29 MTX (B) coated coverslips (n = 6
coverslips per strain). (C) 24-hour attachment to PGM coated coverslips. * indicates p <
0.05; Ordinary oneSEM shown.

In C. difficile
essential for initial host attachment, but could be important for prolonged adherence and
colonization (McKee et al., 2018b). Our 1 hour adhesion assay may have effectively
measured initial attachment, but is insufficient for determining relative long-term
adherence. To control for this, we performed the same adhesion assay previously
described using a 24 hour incubation period. We hypothesized that an extended
incubation period would decrease the relative contribution of flagella and increase the
importance of T4P for promoting prolonged adherence. Surprisingly, relative adherence
trends observed at 24 hours were similar to those obtained at 1 hour (Figure 2.3C). In
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summary, these data demonstrate that a C. difficile R20291 fliC mutant is deficient in
adherence to mucus in vitro.
2.4.4 C. difficile R20291 fliC mutant is deficient in swimming motility
Flagella are primarily known for their role in facilitating motility, often driven by
a chemotactic response (Nakamura & Minamino, 2019). It is therefore not surprising that
C. difficile fliC mutants, which do not produce a flagellum, are non-motile (Baban et al.,
2013; Dingle et al., 2011). The phenotype of our C. difficile R20291 fliC mutant and
complement were evaluated using a swim agar assay. As expected, C. difficile R20291
and fliC complemented strains were motile while the R20291 fliC mutant was deficient in
swimming motility (Figure 2.4). Decreased motility in the intestinal tract during infection
could impact colonization.
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Figure 2.4 A C. difficile fliC mutant strain is deficient swimming motility. Swimming
motility of C. difficile R20291 or flagellar mutant strains in swimming motility agar
(0.175%-0.5xBHIS) following overnight incubation at 37°C.

2.4.5 Competitive exclusion of microbe-mucus interactions by protein blocking
Flagella have previously been shown to impact adhesion by C. difficile R20291
(Baban et al., 2013), but it remains unclear if lack of motility explains decreased
attachment or if the flagellum serves as a direct adhesin. The role of extracellular proteins
in mediating adhesion can be assessed in vitro using a competitive adhesion assay (Arora
et al., 1998; Miyoshi et al., 2006). Proteins assumed to be adhesins are incubated with the
surface of interest to occupy binding sites, then an adhesion assay is performed. For
evaluation of C. difficile flagella, we attempted to obtain a crude flagellar extract
(Tasteyre et al., 2001) for blocking. However, inconclusive results were obtained from
the subsequent adhesion assay and production of large enough quantities of crude
flagellar extract was not feasible for our adhesion model. As such, it was decided to
express and purify recombinant FliC (flagellin) and FliD (flagellar cap) for blocking
experiments.
Recombinant FliD purity was assessed by SDS-PAGE (Figure 2.5A) after
purification by size-exclusion chromatography. Lower molecular weight proteins were
not considered a concern for the purposes of blocking experiments. Following blocking
of immobilized mucus by incubation with protein solutions, relative adhesion of C.
difficile R20291 wild-type was evaluated. Because adhesion assays utilizing mucinderivatized coverslips requires large volumes of protein solutions at high concentration,
the necessary yield of protein was still difficult to achieve despite use of a recombinant
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expression system. The commonly used 96-well plate adhesion assay was therefore
deemed most appropriate for our investigation (Cohen & Laux, 1995). There were no
significant differences observed between mucus-coated wells which were treated with
recombinant proteins and those treated with buffer alone, suggesting that incubation with
CD630 FliD(67-507) did not mask adhesion receptors (Figure 2.5B).
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Figure 2.5 FliD(67-507) blocking does not impact C. difficile adherence to mucus.
(A) Size-exclusion chromatogram and SDS-PAGE gel of FliD(67-507) purification. The
predicted molecular weight of FliD(67-507) is approximately 49.2 kDa. (B) Porcine
colonic mucin (PCM) coated wells of a 96-well polystyrene plate were incubated with
FliD(67-507) or PilA1 (negative control) purified proteins to evaluate potential receptor
blocking. Following incubation with purified proteins, 1-hour adhesion of C. difficile
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R20291 to mucus was evaluated (n = 3 wells per treatment; ns = no significant
difference; Ordinary one-

2.4.6 Swimming motility and mucus adherence vary by strain
C. difficile occupies many environmental niches and colonizes multiple different
hosts, leading to a large degree of intraspecies genetic and phenotypic diversity (Knight
et al., 2015; Knight & Riley, 2019). Relative 1-hour adherence to PGM coated coverslips
was determined for 5 C. difficile strains. BHIS(TA) broth cultures were prepared for each
strain (CD630, R20291, CD2015, CD1015, and VPI-10463), and the mucosal adhesion
assay was performed as described previously. CD1015 had significantly greater
adherence to PGM coverslips than all other strains tested (Figure 2.6A). CD630 was the
least adherent C. difficile strain in our model.
Because we observed that flagella may play an important role in adhesion to
mucus, we also explored phenotypic differences in swimming motility across multiple
strains. To quantitatively assess motility, 0.3xBHIS-0.3% agar was used (AnjuwonFoster et al., 2018), and motility was measured every 24 hours for 72 hours. R20291 and
CD2015 (both ribotype (RT) 027 strains) were highly motile, while CD1015 (RT 078)
and VPI-10463 (RT 003) had very little swimming motility after 72 hours (Figure 2.6B).
Growth curves of each strain in BHIS broth over time were obtained for comparison
using a Tecan Sunrise plate reader (Figure 2.6C).
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Figure 2.6 Comparison of swimming motility and mucus attachment across multiple
C. difficile strains. (A) 1-hour attachment of multiple C. difficile strains to PGM coated
coverslips (* indicates p < 0.05; Ordinary onecomparisons test; n = 2 coverslips per strain with mean and SEM shown). (B) Swimming
motility of C. difficile strains in swim agar (0.5xBHIS-0.3% agar) over time. Data shown
are mean and SEM (n = 3 replicates per strain per timepoint). (C) Growth curve of C.
difficile
replicates per strain with measurements obtained every 15 minutes.

2.4.7 Structural features of mucin impact in vitro adherence
Mucin proteins and their glycosylation varies by host and tissue, offering different
receptors for possible C. difficile binding. To explore the impact of this variation in our
model, coverslips were coated with porcine colonic mucin (PCM), porcine gastric mucin
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(PGM), HT-29 MTX, or LS174T human intestinal epithelial cell-derived mucins.
Relative adherence of C. difficile R20291 wild-type was then assessed following a one
hour incubation as previously described (see section 2.3.6). Adherence to LS174Tderived mucins was significantly greater than to all others tested (Figure 2.7). PCM and
HT-29 MTX-derived mucins had slightly greater adherence than PGM, although the
difference was not statistically significant.

Figure 2.7 Structural and chemical features of mucin facilitate attachment. 1-hour
adherence of C. difficile R20291 to coverslips coated with various mucins (* indicates p
< 0.05; Ordinary onecoverslips per mucin type).

2.5 DISCUSSION
Adhesion to the mucus layer is an important step in colonization for many enteric
bacteria, and recent studies have provided evidence that C. difficile associates with mucus
during infection (Engevik et al., 2015, 2021; Semenyuk et al., 2015). Using a quantitative
model of in vitro adhesion to mucus, we also observed that C. difficile preferentially
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adheres to mucus. By covalently immobilizing mucin molecules onto glass coverslips
(Engevik, Engevik, et al., 2021; Landry et al., 2006), the in vitro model used in this
investigation allows for direct evaluation of microbe-mucus specific interactions without
interference from hydrophobic interactions with polystyrene. As previously observed
(Engevik, Engevik, et al., 2021), when O-linked glycans were removed from mucin
molecules, adhesion of C. difficile to the mucin backbone was reduced. These data
demonstrate that O-linked glycans play a role in facilitating adhesion by C. difficile,
potentially mediating its ability to colonize. Understanding exactly which glycans
promote adhesion may offer novel therapeutic alternatives which decrease virulence
without directly killing C. difficile, protecting against the development of treatment
resistance.
While a number of different cell-surface proteins have been implicated in the
attachment of C. difficile to the host, current findings are often conflicting and in vitro
models fail to account for the presence of the mucus layer. In our in vitro model, flagella,
but not T4P, appear to play a role in initial attachment of C. difficile to mucus.
Interestingly, attachment to mucus appeared to be enhanced in a T4P-null pilA1 mutant,
though possible pleiotropic changes in gene regulation make these results difficult to
interpret. Because T4P were found to promote prolonged attachment to MDCK cell
monolayers by C. difficile

(McKee et al., 2018), future transcriptomic work

investigating gene expression in the pilA1 mutant used in our investigation is warranted.
The importance of flagella is not surprising as many other groups have previously
reported flagella to be an adhesive appendage used by C. difficile (Stevenson et al., 2015;
Tasteyre et al., 2001).
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Even though we observed that the loss of flagella resulted in deficient adherence
-driven motility, or if they
are a direct adhesin (Stevenson et al., 2015). In Psuedomonas aeruginosa, FliD has been
found to directly mediate attachment to mucus (Arora et al., 1998). Attempted blocking
of mucus receptors with recombinantly expressed FliD protein (flagellar cap) had no
impact on C. difficile mucus adherence, suggesting that FliD is not a direct adhesin.
However, part of the N-terminus of FliD was not included in our expression construct (to
increase protein product solubility) and this portion of the native protein should still be
explored as a potential adhesin. We also attempted to perform blocking experiments with
a FliC construct found in the literature (Ghose et al., 2016), but the recombinant product
obtained was found to be in inclusion bodies. Future experiments should be performed to
investigate recombinant FliC as well as crude intact flagellum as potential adhesins to
mucins.
Surprisingly, comparison of relative adhesion to PGM across multiple strains of
C. difficile found that CD1015, an RT 078 strain, was most adherent. RT 078 strains are
highly prevalent in pigs and cattle (Goorhuis et al., 2008), so this could potentially be a
sign of host tropism. However, as with other RT 078 strains, we found that CD1015 was
practically non-motile in a swimming motility assay. Therefore, if flagella do play a role

adherence and flagellar motility is dispensable. Many proteins other than flagella are

enhanced attachment. Adhesion comparisons of a larger, more diverse library of strains
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coupled with analysis of isolate genomic data could bring clarity to these phenotypic
differences.
When comparing adhesion of C. difficile R20291 (human clinical isolate) to
animal and human cell-derived mucins, we observed the greatest attachment to mucins
from LS174T human epithelial cells. Adherence to PGM, mucins which are widely used
in adhesion studies due to their commercial availability, was lowest of those tested. PGM
has been shown to contain virtually no sialylated oligosaccharides while human intestinal
mucins were found to be highly acidic (Ringot-Destrez et al., 2018). Based on these
results, this may suggest that acidic glycan epitopes like sialic acid are important for
adherence by human isolates of C. difficile. Furthermore, LS174T cells are known to
have greater expression of MUC2 mucin than HT-29 MTX cells (Bu et al., 2011) and
also had greater C. difficile attachment suggesting that MUC2 may contain important
adhesion receptors, as was previously hypothesized (Engevik, Engevik, et al., 2020).
In conclusion, C. difficile preferentially adheres to O-linked glycans found on
mucin molecules. Flagella appear to play a role in this process, although the mechanism
by which they facilitate attachment remains unclear and should be a focus of future
investigations. Given that mucin expression and glycosylation vary widely between
healthy and diseased tissues and also different hosts, more attention should be given to
identifying differences in mucins between healthy and CDI individuals as this could
provide insight into disease susceptibility. Because mucin glycans are known to inhibit
virulence factor expression in mucus-associated pathogens like P. aeruginosa and C.
albicans (Takagi et al., 2022; Wheeler et al., 2019), their ability to modulate C. difficile
virulence should be explored for novel therapeutic development.
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CHAPTER THREE: MUCIN ENZYMATIC MODIFICATION BY
PRIMARY DEGRADERS ALTERS C. DIFFICILE ADHERENCE
3.1 ABSTRACT
Several bacterial species that reside in the mucus layer of the gastrointestinal tract
harbor the enzymes necessary for removing glycans from mucin molecules. The liberated
monosaccharides can be used as nutrients by these primary degraders or benefit other
microbes like C. difficile through nutrient cross-feeding. Enzymatic cleavage of mucin
glycans can also mediate the availability of specific glycan epitopes necessary for
attachment by bacterial adhesins or their toxins. Therefore, the ability of Bacteroides
thetaiotaomicron or Ruminococcus gnavus or their cell-free supernatants to modulate in
vitro attachment of C. difficile to mucus-coated coverslips was investigated. Enzymatic
activity of both the live microbes and their respective supernatants was capable of
reducing C. difficile
repertoire of these bacteria may facilitate a greater understanding of the inter-microbial
competition between C. difficile and other mucus-associated species.

3.2 INTRODUCTION
Metabolic and ecological perturbation of the healthy colonic microbiota following
antibiotic therapy, or by other means, is known to favor C. difficile infection. As
previously discussed in Chapter 1, protection from infection afforded by the natural gut
flora, known as colonization resistance, is mediated through both direct and indirect
mechanisms. Direct mechanisms include the production of antimicrobials (Mathur et al.,
2014), competition for nutrients (Aguirre et al., 2021; Leslie et al., 2021; Wilson &
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Perini, 1988), and metabolism of bile acids (Allegretti et al., 2016; Tam et al., 2020).
Indirect mechanisms which protect the host include microbial production of short-chain
fatty acids (SCFAs) and polyamines, as well as amino acid metabolism (Pérez-Cobas et
al., 2015). The complex community of mucus-associated bacteria inhabits a distinct
ecological niche in the digestive tract. Due to its uniqueness, there are likely unexplored
mechanisms of colonization resistance that occur within the mucus layer to protect
against infection by C. difficile and other enteric pathogens.
A major driver of microbial community interactions at the mucus layer involves
the production of hydrolytic enzymes which cleave the oligosaccharide side chains of
community are
primary-degraders (Hoskins et al., 1985), or microbes that harbor the hydrolytic enzymes

enzymes for direct cleavage still benefit through cross-feeding mechanisms. For example,
25 C. difficile genomes surveyed were found to lack the genetic capacity for O-linked
glycan removal and C. difficile R20291 was unable to grown on mucins as a sole carbon
source in vitro (Engevik, Engevik, et al., 2020). Despite this, C. difficile growth on mucin
as a sole carbon source was possible following glycan enzymatic cleavage by coincubation with the primary degraders Akkermansia muciniphila, Bacteroides
thetaiotaomicron, or Ruminococcus torques.
The importance of cross-feeding by C. difficile has also been observed in a mouse
experiments. B. thetaiotaomicron is a primary degrader capable of cleaving sialic acids
from mucin, but lacks pathways required for their catabolism once liberated. C. difficile
does possess catabolic pathways for sialic acid metabolism, and the genes responsible are
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upregulated following monosaccharide liberation by B. thetaiotaomicron in vivo (Ng et
al., 2013). Therefore, liberated mucin-derived monosaccharides provide an important
nutrient source for C. difficile during colonization and outgrowth. However, in addition to
liberating sialic acid, B. thetaiotaomicron has also been shown to increase goblet cell
differentiation and the ratio of sialylated to sulfated mucins in mono-associated rats
(Wrzosek et al., 2013). Therefore, beyond nutrient cross-feeding, primary mucin
degrading species could also influence C. difficile
host mucin production and glycosylation, particularly under conditions of a perturbed gut
ecosystem. To fully understand conditions which promote colonization or dictate disease
severity, pathogen, host, and microbiota interactions must all be taken into consideration.
In addition to liberating nutrients, the hydrolytic activity of primary degraders
also has the potential to expose or destroy adhesin receptors necessary for attachment by
microbes or their toxins. By influencing available receptor sites, mucus-associated
bacterial species play a key role in determining which commensal and pathogenic
microbes are able to colonize and persist in the gut mucosa. For example, in a recent
preprint, desulfation of mucin glycans by B. thetaiotaomicron was shown to decrease
binding of Escherichia coli to mucin (Al-Saedi et al., 2017).
We speculate that modification of the structural and chemical features of the
mucus layer by commensal microbes is a plausible additional mechanism of colonization
resistance against C. difficile. Therefore, the aim of this investigation was to begin
characterizing the bacterial species and enzymatic functions which impact C. difficile
adhesion to the mucus layer through modification of surface-exposed receptors. Using
our in vitro model of mucus adherence, we explored the capacity of B. thetaiotaomicron
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and Ruminococcus gnavus to biologically modify surface-exposed glycans and examined
the impact of these modifications on C. difficile
potential of other bacterial species to alter the prevalence of C. difficile ligand receptors
may allow for the development of precision biotherapeutics for improved treatment of
CDI.

3.3 MATERIALS AND METHODS
3.3.1 Bacterial strains and growth conditions
B. thetaiotaomicron VPI-5482 and R. gnavus were kindly provided by the labs of
Drs. Robert Hutkins and Jennifer Auchtung, respectively, at the University of NebraskaLincoln. Before use in experiments, B. thetaiotaomicron was selectively isolated on
Brain-Heart Infusion (BHI; Remel) media supplemented with 5 g/L yeast extract, 0.5 g/L
L-cysteine, 0.5 g/L hemin, 4 mg/mL gentamicin, 100 mg/mL kanamycin, and 30 mg/mL
novobiocin to obtain pure cultures (Ho et al., 2017). To confirm the identity of the B.
thetaiotaomicron VPI-5482 isolate, PCR was performed using the species-specific
-AACAGGTGGAAGCTGCGGAAGCCTCCAACCGCATCAA-

(Teng et al., 2004).

Overnight cultures of C. difficile R20291 were grown from frozen glycerol stocks
on BHIS(TA) agar plates at 37°C in an anaerobic chamber (as described in Chapter 2).
For experiments, individual colonies from overnight plates were used to inoculate
BHIS(TA) broth.

3.3.2 Biological mucin modification by live primary degraders
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The ability of R. gnavus and B. thetaiotaomicron to modulate C. difficile
adherence to mucin was investigated using an in vitro coverslip adherence assay similar
to the one described in Chapter 2 (2.3.5). Individual colonies of R. gnavus or B.
thetaiotaomicron were used to inoculate BHIS broth, and cultures were grown to midexponential phase (approximately 4-5 hours). Bacterial cultures or BHIS alone were then
added to sterile 6-well cell culture plates containing PCM-coated (porcine colonic mucin)
coverslips, and plates were incubated at 37°C anaerobically for 3 hours.
Following incubation, PCM coverslips were washed 3 times with pre-reduced
PBS to remove attached R. gnavus and B. thetaiotaomicron cells. To ensure full removal
of cells, the coverslips were removed from the anaerobic chamber and exposed to
environmental oxygen while simultaneously treated in a digital laboratory ultraviolet
oven for 3 minutes (Stratalinker UV Crosslinker; Stratagene). Coverslips were then
returned to the anaerobic chamber and quickly washed three times with 10 mL of
anaerobic PBS for further removal of attached bacterial cells. C. difficile R20291
suspended in PBS (OD600=2.0) was added to the wells, and the remainder of the
mucosal adhesion assay was performed as before (see section 2.3.5), with the exception
of enumeration media. C. difficile selective taurocholate-cycloserine-cefoxitin-fructose
agar (TCCFA) (Edwards et al., 2013) was used to ensure accurate quantification of C.
difficile colony forming units (CFU) alone.
3.3.3 Sialidase activity of cell-free supernatants

To evaluate the sialidase activity of cell-free supernatants (CFS), the
commercially available fluorogenic substrate 4-Methylumbelliferyl N-acetyl-a-D-
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neuraminic acid sodium salt (4MU-Neu5Ac; Carbosynth) was used as previously
described (Crost et al., 2013). Colonies of B. thetaiotaomicron and R. gnavus were used
to inoculate BHIS broth supplemented with 0.3% (w/v) PGM. Cultures were grown at
37°C under anaerobic conditions. After 24 hours of growth, 1 mL aliquots (2 x each
strain) were collected. Cells were removed from aliquots by centrifugation (17,000 x g, 5
min., 4°C). The resulting supernatant from one aliquot of each strain was then passed
through a 0.45 µm filter (VWR), while activity of the second aliquot was evaluated
without filtration. 50 mL of each supernatant was transferred to a black 96-well plate
(Corning) and 150 mL of 650 mM 4MU-Neu5Ac (Carbosynth) in PBS (pH 7.40) was
added to each well as substrate. Reactions were carried out at 37°C for 2.5 hours with
continuous orbital shaking using a BioTek Synergy H1 plate reader. Fluorescence
measurements (Excitation 360 nm., Emission 465 nm.) were obtained every 5 minutes.
Relative fluorescence unit (RFU) values obtained at 20 and 40 minutes were used to
determine relative rates of MU release per minute (see Figures 3.1C&D) after subtracting
negative control measurements (BHIS + mucus; no enzyme).
3.3.4 Biological mucin modification by cell-free supernatant
Cell-free supernatant from B. thetaiotaomicron VPI-5482 was evaluated for its
ability to modulate C. difficile

-binding capacity. Following overnight growth,

colonies of B. thetaiotaomicron were used to inoculate BHI media supplemented with 5
g/L yeast extract, 0.5 g/L L-cysteine, 0.5 g/L hemin, and 0.3% type III porcine stomach
mucin (HiMedia Laboratories). Following 48 hours of anaerobic growth at 37°C, the
culture was centrifuged (3,000 x g, 10 min., 4°C) and the resulting supernatant was
passed through a 0.2 mm bottle-top filter (ThermoFisher Cat No. FB12566512). Filtered
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supernatant containing putative mucin-degrading enzymes, boiled supernatant, or media
alone were then incubated with porcine colonic mucin coated coverslips overnight at
37°C. Following treatment, incubation solutions were removed and coverslips were
gently washed with sterile PBS (pH 7.2). The mucosal adhesion assay was then
performed with C. difficile R20291 as previously described (see Chapter 2 Materials and
Methods).

3.4 RESULTS
3.4.1 R. gnavus and B. thetaiotaomicron decrease mucosal adherence by C. difficile
B. thetaiotaomicron and R. gnavus, two mucin-degrading bacterial species, were
incubated with PCM-coated coverslips to allow for enzymatic modification of available
surface glycans by the live microbes. Following enzymatic modification, relative
attachment of C. difficile R20291 to the coverslips decreased for both bacterial species
when compared to control coverslips incubated with BHIS alone (Figure 3.1A). Because
mucin degrading species are known to secrete the hydrolytic enzymes necessary for
glycan cleavage, the ability of cell-free supernatant of B. thetaiotaomicron grown in the
presence of mucin was also used to treat PCM-coated coverslips. Adherence by C.
difficile R20291 was similarly significantly decreased (Figure 3.1B) compared to a BHIS
treated control coverslip or coverslip treated with boiled cell-free supernatant.
3.4.2 Sialidase activity of cell-free supernatants from primary degraders
To begin characterizing the enzymatic activity of cell-free supernatants from
primary mucin-degrading species grown in the presence of mucin, the fluorogenic
substrate 4MU-Neu5Ac was used (Crost et al., 2013). As a substrate, 4MU-Neu5Ac is
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hydrolyzed by sialidase activity to release 4-methylumbelliferone (4MU) (Minami et al.,
2021). The resulting molecule is fluorescent, allowing for detection of relative
fluorescence units (RFU) for quantitative comparison of sialidase activity over time
(Figure 3.1C). When compared to substrate hydrolysis of the negative control (BHIS
supplemented with mucin; no enzyme), both filtered and un-filtered cell-free supernatants
from B. thetaiotaomicron and R. gnavus cultures demonstrated sialidase activity (Figure
3.1D).
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Figure 3.1 Primary mucin degrading bacteria influence C. difficile adherence to
mucin. (A) Attachment of C. difficile R20291 to PCM coverslips following 3-hour
coverslip incubation with B. thetaiotaomicron (Bt), R. gnavus (Rg), or BHIS (control)
with n = 3 coverslips per treatment (Ordinary onecomparisons test). (B) R20291 attachment to PCM coverslips following overnight
incubation of coverslips with B. thetaiotaomicron cell-free supernatant (CFS), heatinactivated CFS (HI-CFS), or growth media alone (control) with n = 3 coverslips per
treatment (Ordinary one(C)
Sialidase actitvty of Bt and Rg cell-free supernatants (CFS), filtered CFS (F_CFS), or
BHIS supplemented with 0.3% porcine gastric mucin as determined by relative
fluorescence units (RFU) (n = 4 reactions per condiition). (D) Relative sialidase activity
of Bt and Rg CFS or F_CFS after subtraction of control reaction from the linear portion
of Fig. 3.1C (t=20 min. to t=40 min.).

3.5 DISCUSSION

Ruminococcus gnavus and Bacteroides thetaiotaomicron are two mucindegrading microbes which are thought to cross-feed C. difficile during infection through
enzymatic cleavage of mucin glycans (Engevik, Engevik, et al., 2020; Ng et al., 2013).
By modulating nutrient availability, these interactions may shape disease susceptibility
and progression during CDI. Because C. difficile appears to colonize the mucus layer
during infection (Semenyuk et al., 2015), we speculated that mucin glycan cleavage
would also modify the accessibility of bacterial adhesin receptors on the surface of mucin
molecules, thereby impacting C. difficile attachment. When an artificial mucus layer
consisting of immobilized porcine colonic mucins was briefly incubated with R. gnavus
or B. thetaiotaomicron, we observed a subsequent decrease in relative mucin adhesion by
C. difficile. Similarly, treatment with cell-free supernatant from B. thetaiotaomicron also
decreased adhesion. These results suggest that primary mucin degrading species could
influence C. difficile colonization by directly altering the epithelial surface glycan
landscape and receptors available for attachment. Further characterization of this
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enzymatic activity and confirmation of putative mucin glycan hydrolysis is necessary to
better understand their relevance to C. difficile colonization. Targeted biological glycan
modification in combination with rationally selected microbial consortiums known to
deplete NeuAc and GlcNAc sugars (Pereira et al., 2020) could greatly reduce dependency
on destructive courses of antibiotic therapies administered to treat resistant and recurrent
CDI.
While C. difficile is thought to utilize sialic acid liberated by mucin-degrading
microbiota following antibiotic disruption (Ng et al., 2013), other bacterial species also
likely benefit from an aberrant nutrient landscape. For example, similar to C. difficile,
Fusobacterium nucleatum does not harbor the enzymes necessary for sialoglycan
foraging but does encode the machinery required for their transport and catabolism
(Agarwal & Lewis, 2021). Interestingly, it was recently reported that F. nucleatum and C.
difficile co-aggregate in the context of an in vitro mixed microbial community, promoting
biofilm formation and changes in the expression virulence-associated genes (Engevik,
Danhof, et al., 2020). It may therefore be possible that increased levels of mucin-derived
monosaccharides (e.g., free sialic acid) promote synergistic interactions between crossfeeding benefactors like F. nucleatum and C. difficile. In the context of CDI, in addition
to interactions with mucin-degraders, understanding polymicrobial relationships with
other cross-feeding species may further elucidate mechanisms of inter-microbial
competition which control or potentiate disease.
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